Detalhe da pesquisa
1.
ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice.
Mol Ther
; 32(5): 1359-1372, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429929
2.
Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 Mice.
Ann Neurol
; 94(4): 658-671, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243335
3.
Impaired Oligodendrocyte Maturation Is an Early Feature in SCA3 Disease Pathogenesis.
J Neurosci
; 42(8): 1604-1617, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042771
4.
An Essential Role for Alzheimer's-Linked Amyloid Beta Oligomers in Neurodevelopment: Transient Expression of Multiple Proteoforms during Retina Histogenesis.
Int J Mol Sci
; 23(4)2022 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216328
5.
Disease-associated oligodendrocyte signatures are spatiotemporally dysregulated in spinocerebellar ataxia type 3.
Front Neurosci
; 17: 1118429, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36875652
6.
Blood neurofilament light chain levels are associated with disease progression in a transgenic SCA3 mouse model.
bioRxiv
; 2023 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36909535
7.
Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3.
Dis Model Mech
; 16(9)2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664882
8.
Pathogenetic Mechanisms Underlying Spinocerebellar Ataxia Type 3 Are Altered in Primary Oligodendrocyte Culture.
Cells
; 11(16)2022 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36010688
9.
Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown.
Neural Regen Res
; 18(10): 2192-2193, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37056132